Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds

• Published in: BMJ Vol. 369; p. m2263
• Main Author: Torjesen, Ingrid
• Format: Journal Article Web Resource
• Language: English
• Published: London British Medical Journal Publishing Group 08.06.2020; BMJ Publishing Group LTD
• Subjects: Azithromycin; Coronaviruses; COVID-19; Dexamethasone; Hospitals; Hydroxychloroquine; Infectious diseases; Lopinavir; News; Patients; Prophylaxis; Ritonavir; United Kingdom > UK

Hydroxychloroquine does not reduce the risk of dying or improve other outcomes in hospitalised patients treated for covid-19, preliminary results from the UK RECOVERY trial have shown. Announcing the results, Martin Landray, the study’s deputy chief investigator, said, “We have concluded that there...